Objective: To investigate the relationship between trauma center volume and outcome. Background: The Resuscitation Outcomes Consortium is a network of 11 centers and 60 hospitals conducting emergency care research. For many procedures, high-volume centers demonstrate superior outcomes versus low-volume centers. This remains controversial for trauma center outcomes. Methods: This study was a secondary analysis of prospectively collected data from the Resuscitation Outcomes Consortium multicenter out-of-hospital Hypertonic Saline Trial in patients with Glasgow Coma Scale score of 8 or less (traumatic brain injury) or systolic blood pressure of 90 or less and pulse of 110 or more (shock). Regression analyses evaluated associations between trauma volume and the following outcomes: 24-hour mortality, 28-day mortality, ventilator-free days, Multiple Organ Dysfunction Scale incidence, worst Multiple Organ Dysfunction Scale score, and poor 6-month Glasgow Outcome Scale-Extended score. Results: A total of 2070 patients were evaluated: 1251 in the traumatic brain injury cohort and 819 in the shock cohort. Overall, 24-hour and 28-day mortality was 16% and 25%, respectively. For every increase of 500 trauma center admissions, there was a 7% decreased odds of 24-hour and 28-day mortality for all patients. As trauma center volume increased, nonorgan dysfunction From the complications increased, ventilator-free days increased, and worst Multiple Organ Dysfunction Scale score decreased. The associations with higher trauma center volume were similar for the traumatic brain injury cohort, including better neurologic outcomes at 6 months, but not for the shock cohort. Conclusions: Increased trauma center volume was associated with increased survival, more ventilator-free days, and less severe organ failure. Trauma system planning and implementation should avoid unnecessary duplication of services.
T he American College of Surgeons (ACS) Resources for Optimal Care of the Injured Patient requires that level I trauma centers have at least 1200 yearly admissions. 1 This minimal volume criterion has been based on the argument that high-volume trauma centers will have adequate resources and expertise to provide the highest quality patient care and have the best outcomes. This has been a source of debate regarding whether level I centers have higher survival rates than level II trauma centers. There have been many studies that both support [2] [3] [4] [5] and refute 6, 7 this volume-outcome debate. Others suggest that it is not the volume of trauma admissions but a level I designation of the trauma center that results in better outcomes. 8, 9 The Resuscitation Outcomes Consortium (ROC) was established to perform out-of-hospital resuscitation studies in cardiac arrest and severe trauma. Eleven centers from 9 regions throughout North America make up the consortium. Two randomized controlled trials were performed to study out-of-hospital hypertonic saline resuscitation in severely injured patients: one study in patients with presumed hypovolemic shock 10 and the other with severe traumatic brain injury (TBI). 11 Both studies were stopped for futility before enrollment was completed but not before 2222 patients were enrolled.
We sought to revisit the volume-outcome, designation-leveloutcome question. The aim of this study was to perform a secondary analysis of shock and TBI patients enrolled in the Hypertonic Saline Trial to determine whether there was an association between volume of trauma center admissions or level of designation and important health outcomes. We also sought to determine whether there was an association between volume or designation level and rate of postinjury complications. Our hypothesis was that higher trauma center admission volume or level I designation would confer a survival advantage over low-volume or level II-designated trauma centers.
coordinating center in the United States and Canada. Local institutional or ethics review boards at all sites approved the original studies. The trial involved 114 emergency medical services agencies within the catchment areas served by the ROC. Two clinical trials were conducted simultaneously with the same intervention. The trials had 2 distinct patient cohorts, one for hypovolemic shock and the other for TBI. This report is a secondary analysis of both cohorts. The primary studies were randomized, controlled, double-blinded, 3-arm clinical trials comparing a 250-mL prehospital bolus of 7.5% saline (hypertonic saline) versus 7.5% saline with 6% dextran 70 versus 0.9% saline as the initial resuscitation fluid given to injured patients with hemorrhagic shock or TBI in the out-of-hospital setting. Details of the initial study designs and primary outcomes have been previously published. [10] [11] [12] 
Patient Population
Patients were included in the hypovolemic shock cohort if they had out-of-hospital systolic blood pressure of 70 mm Hg or less or 71 to 90 mm Hg with a concomitant heart rate of 108 beats or more per minute. Patients were included in the TBI cohort if they had a blunt mechanism of injury and a Glasgow Coma Scale (GCS) score of 8 or less and did not meet criteria for the shock cohort. Patients who met criteria for the shock cohort and who also exhibited inclusion criteria for the TBI cohort were included in the shock cohort. Exclusion criteria were the following: known or suspected pregnancy; age less than 15 years; out-of-hospital cardiopulmonary resuscitation; administration of more than 2000-mL crystalloid, colloid, or blood products before enrollment; severe hypothermia (<28 • C); drowning or asphyxia due to hanging; burns more than 20% total body surface area; isolated penetrating head injury; inability to obtain intravenous access; time of dispatch call received to study intervention more than 4 hours; and known prisoners. Interfacility transfers were also excluded. Once admitted, patient care was not proscribed, but investigators agreed to follow a set of standard operating procedures (SOPs) promulgated by the Inflammation and the Host Response to Injury Investigators. These SOPs included low tidal volume ventilation strategies for acute respiratory distress syndrome, 13 strict hyperglycemia management, 14 and restrictive transfusion practices. 15 The primary independent variables of interest were the level of trauma center designation and the yearly volume of trauma center admissions. The local state (United States) or provincial (Canada) designating authorities determined trauma center designation level, and only level I and II centers were included in the analysis. Trauma center volume was determined from local hospital registry data for patients who met trauma registry inclusion criteria and were admitted to the hospital or died in the emergency department (ED) during the time frame of the parent studies.
The dependent variables analyzed were 24-hour and 28-day mortality, the rates of both infectious and noninfectious complications, the proportion of patients with 6-month Glasgow Outcome Scale-Extended (GOSE) score of 4 or less (TBI-only cohort), ventilator-free days, multiple organ dysfunction (MOD) incidence defined as Multiple Organ Dysfunction Scale (MODS) score of more than 6, and worst MODS score. A GOSE score of 4 or less is considered severe disability (GOSE score = 3 or 4), vegetative state (GOSE score = 2), or death (GOSE score = 1). 16 Both MOD incidence and worst MODS score were analyzed to evaluate both the odds of developing MOD and the severity of MOD. 17 Noninfectious complications included fat embolism syndrome, cardiac arrest, myocardial infarction, cerebral infarction, deep venous thrombosis, pulmonary embolus, abdominal compartment syndrome, and extremity compartment syndrome. Infectious complications included nosocomial pneumonia, bloodstream infections, and surgical site infections. Nosocomial infection diagnoses had to meet Centers for Disease Control and Prevention (CDC) definitions. Complications were only analyzed in patients admitted to the hospital. Patients who either died in the ED or were discharged from the ED were not considered in the complication analysis.
Statistical Methods
The outcomes of interest were evaluated for both cohorts combined and the TBI and hemorrhagic shock cohorts independently. Patient characteristics, out-of-hospital care, and admission physiology were compared between level I and II trauma centers and trauma volume (increments of 1000) using 2-sided t test, analysis of variance, or χ 2 tests as appropriate. A P value of less than 0.05 was considered significant. Primary and secondary outcomes were also described for the overall population stratified by trauma level and trauma volume.
Multivariable logistic regression accounting for withinhospital correlation using generalized estimating equations were used to evaluate the association between trauma volume and trauma level (separately and combined) for the following outcomes: 28-day mortality; 24-hour mortality; imputed 6-month GOSE score (TBI only cohort); proportion of noninfectious complications and infectious complications; and proportion developing multiple organ failure defined as MODS score of more than 6 after adjusting for other factors. Linear regression accounting for within-hospital correlation was used to evaluate the association with predictors after adjustment for other factors for the following outcomes: ventilator-free days and worst MODS score. Volume was analyzed as a linear continuous variable with results reported per incremental admission increase of 500 patients. Adjustment factors included age, sex, lowest prehospital systolic blood pressure, prehospital GCS score, mode of transportation, use of advanced airway, prehospital time, mechanism of injury, Injury Severity Score (ISS), initial ED systolic blood pressure, head Abbreviated Injury Scale score, and site of enrollment (SAS, version 9.1.3, Cary, NC; Stata, version 11, College Station, TX).
RESULTS
A total of 2222 patients were enrolled in the 2 study cohorts. After exclusions, 2070 patients were analyzed: 1251 in the TBI cohort and 819 in the shock cohort. One hundred fifty-two enrolled patients were excluded from the primary analyses for the following reasons: hypertonic saline bag opened but not given (N = 88); care rendered at more than 1 hospital (N = 39); died before reaching hospital care (N = 16); and missing hospital data (N = 2). Table 1 describes the patient population studied. A higher proportion of patients were male and sustained blunt trauma. Approximately 80% of the patients were brought to a level I hospital; however, these hospitals had annual hospital trauma admission volumes that varied from low-volume to high-volume centers. Study patients had a relatively even admission distribution to low-, medium-, and high-volume trauma centers.
A higher proportion of patients were brought to level I or highvolume centers after sustaining penetrating trauma or after treatment with a prehospital advanced airway. Patients with higher ISS scores were more likely to be taken to level I or high-volume trauma centers. Patients brought to level I or high-volume centers tended to receive more prehospital crystalloid resuscitation.
On hospital arrival, a greater proportion of TBI patients who went to level I or high-volume centers tended to have lower arrival GCS scores and more frequent use of intracranial pressure monitoring. Similarly, a higher proportion of patients enrolled in the shock trial who were brought to level I or high-volume centers were more likely to be acidotic, have early signs of coagulopathy denoted by a higher admission international normalized ratio, and undergo an emergency hemorrhage control procedure. Overall, Table 1 provides evidence that prehospital triage patterns tended to bring more severely 
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Penetrating, n (%) 0 (0) 324 (16) 275 (17) 46 (11) 0.006 31 (11) 114 (23) 86 (20) 71 ( injured and metabolically deranged patients to level I trauma centers or higher volume trauma centers. Despite a higher proportion of severely injured patients being brought to level I and high-volume trauma centers, unadjusted 24hour and 28-day mortality was not different between level I and level II centers or low-volume and high-volume centers (Table 2) . Similarly, although a higher proportion of patients with lower GCS scores were brought to level I and high-volume trauma centers, the proportion of patients with a 6-month GOSE score of 4 or less was also not different between level I and level II centers or low-volume and high-volume centers. Intensive care unit length of stay (LOS), ventilator-free days, and severity of MOD were also not different. A higher proportion of patients developed both noninfectious and infectious complications in high-volume centers. Thus, it seems that although a higher proportion of severely injured patients were brought to level I and higher volume centers, their mortality was no higher than that in level II and lower volume centers. This may have come at the expense of higher complication rates.
To further explore the relationship between trauma center designation, volume, and outcome, multivariable logistic regression was performed to adjust for differences in injury characteristics and determine their influence on outcome (Table 3 ). Data are reported in 500 patient admission increments for clarity of presentation. (However, if a significant finding were reported, it would be present for any volume. The effect would be half as large for increments of 250 and twice as large for increments of 1000.) As trauma center admission volume increased, there were reduced odds of both all-patient 24-hour mortality and 28-day mortality of 7% for every 500 trauma patient admission increase to a trauma center. This effect was maintained in the TBI cohort, but not in the shock cohort, and persisted when both designation level and volume were adjusted together. In addition, there was a 55% relative decrease in 28-day mortality if a patient was in the shock cohort and brought to a level I trauma center versus a level II center. This level effect persisted when additionally adjusting for volume. Although there was a trend toward improved survival for all patients brought to a level I center, this effect did not reach statistical significance. This analysis was repeated after excluding patients with an ISS of less than 16 (data not shown). There were reduced odds of both all-patient 24-hour mortality and 28-day mortality of 5% and 6%, respectively, for every 500 trauma patient admission increase to a trauma center. The results for the individual TBI and shock cohorts mirrored the results described earlier.
In the TBI cohort, increasing trauma center volume by every 500 admissions was associated with an 8% odds reduction in having a poor neurologic outcome as measured by 6-month GOSE score of 4 or less. There was no effect on 6-month GOSE outcomes based on trauma center designation. When additionally adjusting for center designation, admission to a high-volume center was associated with better long-term neurologic outcomes.
Secondary outcomes explored were both noninfectious and infectious complications ( Table 4 ). As trauma admission volume increased, there was an increase in all-patient risk of noninfectious complications. However, infectious complications were not increased in the all-patient group. Similarly, as trauma center volume increased, there was an increased risk of noninfectious complications, but not infectious complications, in the shock cohort. This was not seen in the TBI cohort where there was no increased risk of either infectious or noninfectious complications. These findings persisted when volume and designation level were analyzed in the same model. Conversely, there was a higher risk of infectious complications in all patients brought to a level I trauma center. Noninfectious complications were not increased. Interestingly, the shock cohort had an increased risk of both infectious and noninfectious complications when patients were brought to a level I center. There was no effect on both infectious and (25) 397 (24) 102 (25) 0.6687 69 (24) 116 (23) 105 (24) 149 (24) 0.9828 24-h mortality, n (%) (16) 254 (16) 64 (16) 0.861 41 (14) 74 (15) 71 (16) 96 (15) 528 (29) 446 (30) 81 (23) 0.0093 67 (27) 111 (25) 104 (26) 191 (32) 0.0459
Nosocomial pneumonia, n (%) 221 (10.7) 353 (19) 295 (20) 58 (17) 0.155 48 (20) 68 (15) 74 (19) 127 (21) 0.0848
Bloodstream infections, n (%) 221 (10.7) 117 (6) 101 (7) 16 (5) 0.1443 21 (9) 15 (3) 26 (7) 37 (6) 0.0259
Noninfectious comp, n (%) 220 (10.6) 247 (13) 206 (14) 39 (11) 0.1641 25 (10) 43 (10) 60 (15) 98 (17 noninfectious complications in the TBI-only cohort when brought to a level I versus level II center. When volume and designation level were analyzed together, all differences in the all-patient and shock cohorts were lost. These data taken together suggest that trauma center volume rather than designation level drove the effect on infectious and noninfectious complications.
To explore factors that may be in part responsible for outcome differences between level I and II-designated centers and lowand high-volume trauma centers, multivariate logistic regression was performed to determine the odds of developing MOD defined as an MODS score of more than 6 ( Table 4 ). Despite more severely injured patients being admitted to high-volume and level I centers, there were no increased odds of patients developing MOD when either volume or designation level was analyzed separately. However, there were increased odds of developing MOD in the shock cohort as volume of patients increased when additionally adjusting for designation level. Conversely, there were decreased odds of developing MOD in the TBI cohort as volume increased and designation level was considered in the model. Finally, linear regression was performed to determine whether there were differences in intensive care unit LOS, ventilatorfree days, and severity of organ failure measured as worst MODS score ( Table 4 ). As trauma admission volume increased, there was an increase in all-patient ventilator-free days and a decrease in worst MODS score. There was a similar effect seen in the TBI-only cohort but not in the shock cohort. There was no effect on ventilator-free days or worst MODS score between level I and II-designated centers. These effects were unchanged when volume and designation level were adjusted together. There was no effect of volume or designation level in any group on intensive care unit LOS (data not shown). The interaction between volume and designation center was explored, but no difference in effect was seen.
DISCUSSION
The debate centered on whether volume of trauma patients admitted or level of trauma center designation has any bearing on patient outcome has been active for decades. This study shows that as trauma center volume increases, the odds of 24-hour and 28-day mortality decreases. This effect was maintained as volume increased to very high admission numbers of greater than 3000 trauma admissions per year. This effect was sustained when looking at the TBI study cohort alone but not the shock study cohort. Patients brought to a designated level I trauma center had half the odds of mortality than patients brought to a designated level II center in the shock-only cohort.
Multiple studies have looked at the effect of trauma center volume on outcome. Many of these studies relied on administrative data sets, 5, 18, 19 statewide registries, 8, [20] [21] [22] or the National Trauma Data Bank 2,7,9 where accuracy and validity of data have been questioned. [23] [24] [25] An advantage of this study is that it is based on prospectively collected data with quality control and review and does not rely on administrative data sets or registry downloads. This is a major strength of the findings of this study.
Nathens et al 5 showed that high-volume trauma centers, defined as having greater than 650 admissions per year with an ISS of more than 15, had significant reductions in mortality only for the most severely injured patients with either isolated penetrating injuries with shock on admission or multisystem blunt trauma with coma on admission. Other studies have both supported [2] [3] [4] 26 and refuted 6, 7, 9 the premise that increased trauma center volume results in better outcomes. Our results showed a broad effect on survival in those with severe injuries. This may be due, in part, to the criteria required to be enrolled in this study included only those with evidence of severe injury in the prehospital setting.
Interestingly, our data showed a beneficial effect on 28-day survival in level I centers only in the shock cohort. Others have shown that level I center designation and not volume provides a survival advantage for patients with severe injuries. Demetriades et al 9 showed that in patients with major vascular or hepatic injuries and complex pelvic fractures, level I centers had lower odds of mortality than level II centers even when adjusted for trauma center volume. Cudnik et al, 8 using the Ohio statewide registry data, found that the odds of mortality at level I centers were lower than level II centers. Other authors have shown that in an analysis within level I centers alone, a driving force that determines survival is volume and as trauma center volume increases, the odds of mortality decreases. 2, 19 A possible explanation for our data not showing a 24-hour survival advantage in level I-designated centers may be related to findings in the original study. In the original study reported by Bulger et al, 10 there was a higher mortality rate in the hypertonic saline cohorts in the subgroup of patients who did not receive blood transfusions in the first 24 hours than in the control group receiving normal saline. Our data show that more severely injured patients were brought to high-volume and level I centers. It is possible that this finding in the original study negated any potential benefit of being brought to a level I or high-volume center.
In the original Hypertonic Saline Trial, there was no outcome benefit to being treated with hypertonic saline as compared with normal saline in the TBI cohort. 11 However, in this study, as trauma center volume increased, the odds of mortality and poor neurologic outcome in the TBI cohort decreased. Tepas et al, 19 using Florida statewide administrative data of TBI patients, found similar results. They showed that high-volume centers had a lower risk of mortality and a lower risk of discharge to a skilled nursing facility, suggesting better functional outcomes. 19 Others have shown similar results. 18 Our study showed that even with more severely injured TBI patients being brought to high-volume centers, versus lower volume centers, not only were the odds of survival increased but also the odds of meaningful survival, as measured by 6-month GOSE scores, increased.
Both infectious and noninfectious complications were evaluated in this study. As trauma center volume increased, there was an increased risk of noninfectious complications but not infectious complications. This pattern was sustained for the shock cohort, but not the TBI cohort, where there was no relationship between trauma center volume and any complication. In a recent study from the Inflammation and the Host Response to Injury Investigators, 27 analyzing a similar cohort of severely injured patients, multiple organ failure was associated with injury severity, depth and duration of shock, and aggressive fluid resuscitation. In this study, higher volume trauma centers had a higher proportion of patients with these characteristics, explaining in part this finding. Furthermore, with the data showing that higher volume trauma centers had lower odds of mortality, more severely injured patients at higher volume trauma centers would be alive to get complications than those at lower volume centers. A similar argument can be made for level I centers having a higher risk of developing infectious complications in the shock cohort but not in the TBI cohort, when compared with level II centers. Similar to high-volume centers, level I centers had a significantly decreased risk of mortality compared with level II centers in the shock cohort. A number of investigators have shown an increased risk of infection with higher ISS, 28, 29 shock and acidosis, [29] [30] [31] and coagulopathy with transfusion, 29, 32, 33 all factors that were in higher proportion in patients admitted to level I centers.
To explore potential explanations for our findings, we examined outcomes that were potentially associated with process and postinjury management. Despite more severely injured patients being brought to high-volume and level I centers, they had fewer days on the ventilator and no higher odds of developing MOD, and when patients at these centers did develop MOD, it was less severe as evidenced by lower MODS scores. It is entirely plausible that high-volume centers used SOPs associated with fewer days on the ventilator and faster recovery from organ failure that have been shown to improve outcomes in similar patient populations. 34 The ROC investigators agreed to institute similar SOPs; however, SOP compliance was not strictly measured in this study.
Our analysis could not address whether there was a ceiling to the volume effect in this study when volume overwhelmed resources and outcomes suffered. Arbabi et al 35 looked at the effect of increasing patient volume on outcomes in times of patient surge when resources were fixed. In their single-institution study in a highvolume trauma center, they could find no differences in outcomes based on patient load when resources were strained. 35 Other studies have shown that there were no outcome differences between lowvolume and high-volume surgeons managing trauma patients at the same institution. 36, 37 These studies suggest that high-volume centers have developed practices and procedures that extend beyond the individual trauma surgeon. Perhaps, the results of this trial are due, in part, to high-volume centers having systems in place that not only account for volume with appropriate resources but also processes that allow for efficiency and earlier definitive care. Because there were only 4 centers in this study with annual trauma volumes greater than 3000 admissions per year, we were unable to determine whether there is a limit to the volume effect on outcome.
This study is the first to look at the continuum of trauma care from the out-of-hospital phase through the postadmission phase of care and analyze outcomes and its relationship to trauma center volume. We have previously shown a large variation in outcomes of the various trauma systems that participate in the ROC. 38 On the basis of this known outcome variation within the study collaborators, it is plausible that high-volume centers have worked with their emergency medical services (EMS) counterparts on protocols that deliver advanced trauma care earlier in the out-of-hospital phase of care. These out-of-hospital providers may better appreciate signs of injury severity, institute appropriate care, and preferentially bring these patients to high-volume centers.
This study has potential implications for trauma triage guidelines. The present CDC field triage guideline recommends that those with the potential for being most severely injured based on physiologic, anatomic, or mechanistic criteria "be transported preferentially to the highest level of care within the defined trauma system." 39(p6) The results of this study suggest that these patients should be brought to the highest volume center within the trauma system. When there are multiple trauma centers within a system, should EMS bypass a closer low-volume center to transport a severely injured patient to a higher volume center? The answer to that question is beyond the scope of this study's findings. However, in another study from the ROC on a similar but separate trauma cohort, Newgard et al 40 showed no difference in outcomes of severely injured trauma patients with out-of-hospital times up to 80 minutes compared with those with shorter out-of-hospital times. Taking the CDC guideline together with the results of this study and the study by Newgard et al, it would be reasonable to suggest that severely injured patients be brought to the highest volume center when total out-of-hospital times can remain under 80 minutes. This decision would only be relevant when there are multiple centers in a trauma system that would allow transport within the 80-minute time frame. When out-of-hospital times would exceed this limit as in a rural setting with only a single trauma center, this issue becomes moot.
The ACS Committee on Trauma (COT) presently sets the lower limit of admissions for a level I trauma center at 1200. 1 The results of this study do not define a new standard for trauma center volume. It does suggest that centers with higher volume have better survival than lower volume centers. Redundant trauma center proliferation in urban settings that only reduces existing trauma center admission volume without improving access to care should be scrutinized. Trauma systems should critically evaluate their triage guidelines and consider developing protocols that deliver the most severely injured consistently to the highest volume center.
There are limitations to this study. First, this is a secondary analysis of prospectively collected clinical trial data. The initial data set was not designed to answer these study questions, and it is possible, despite attempts to account for confounding variables, we have not adequately accounted for all factors that needed to be considered. As an example, it is possible that counting trauma admissions was done differently at different trauma centers, reflecting different inclusion criteria between trauma registries.
Second, the results of this study can only suggest associations between improved outcomes and higher trauma center volume. The reason for this potential effect was not delineated by this analysis.
The data suggest that high-volume trauma centers may have systems in place that better prepare them to deliver definitive trauma care. This statement can only be inferred from the data, and no cause and effect conclusions can be drawn.
Third, the results of this study may not be generalizable. The data collected for this analysis were in the context of a randomized trial of out-of-hospital use of hypertonic saline after severe injury with or without TBI. All personnel from out-of-hospital providers to accepting hospital providers were aware of this fact. It is possible that in all phases, care delivered would be somehow different than if a patient were not enrolled in the parent study.
Finally, only total trauma center volume was used in this analysis. There was no account for volume of severe injuries admitted to any institution. It is possible that by analyzing only total trauma center volume, important differences in the volume of severely injured trauma patients were missed. If a given trauma center had a high volume of total trauma admissions but a low volume of severely injured trauma admissions, the benefit of being a high-volume center may not extend to the most severely injured. Conversely, if a low-volume center had a high proportion of severely injured patients admitted to its center, the center might be better able to manage more severely injured patients. These arguments are however counterintuitive to the results found and would have also tended to weaken the findings of this study.
CONCLUSIONS
The results of this study show that severely injured patients admitted to a higher volume trauma center have a lower odds of mortality than if they are brought to a lower volume trauma center. This survival benefit was associated with added complications, but high-volume centers were able to mitigate the consequences of these events. This may be partly related to improved processes and protocols that lead to fewer days on the ventilator and less severe organ failure. High-volume trauma centers likely have systems in place to deliver the highest quality efficient trauma care to the most severely injured patients brought to their centers. Thus, out-of-hospital triage guidelines should bring the most severely injured patients to the highest volume centers. Trauma center proliferation should be approached with caution due to the volume reduction effect resulting from a wider distribution of the same number of patients to more trauma centers. Further study is warranted to define the factors that lead to improved outcomes at high-volume centers.
DISCUSSANTS

M. Rotondo (Rochester, NY):
The ROC consortium has been an extremely productive group of investigators and we should express our appreciation for their considerable contributions to the literature. This study is a secondary analysis of a data set and it's very creative use of the data, and a very well-constructed study.
You can see that they have properly identified the weaknesses and limitations of the work and, in fact, they discuss them extensively in the manuscript and quite sufficiently, so I won't review them here. In fact, the results and conclusions, for the most part, resonate with my experience.
Serendipitously, this study comes to light coincident with a very germane set of questions that we have struggled with at the ACS COT for what seems like time immemorial. First, do the structure and process standards, as outlined in the Resource for Optimal Care of the Injured Patient differentiate, level I and level II center outcomes? Second, does total admission volume make a difference? Now, having just toiled through the process of revising the Resources for Optimal Care of the Injured Patient over the last 4 years, I can tell you from firsthand experience, it's likely easier to perform this kind of study than it is to manage the vagaries of the political boondoggle of trauma centers and trauma systems in the 21st century. If you layer in a heavy dose of commoditization of trauma care, one begins to believe that no amount of credible science will lead us to a viable resource-conscious, value-based, patient-centered solution for injured patients in America.
Now let me explain what I mean.
Your study demonstrated that the patients who ended up at level I centers had slightly higher injury severity scores, more often suffered penetrating injury, and were more often in shock. But if you look at broader data sets, one can find little if any differentiation in triage between level I and level II centers. This is the case despite the fact that in her 2006 The New England Journal of Medicine publication, Ellen McKenzie demonstrated a significant survival advantage for seriously injured patients admitted to level I centers. Now, the problem is that in most trauma systems today, there is little if any relationship between triage guidelines, destination protocols, and activation protocols. Furthermore, the 2011 CDC field triage guidelines recommend that injured patients who meet physiologic or anatomic criteria be transported to a trauma center, almost parenthetically with preference to the highest level of care. This second stipulation, for the most part, is unenforced and ignored by lead agencies across the country.
So, then my first question is "Are your data strong enough to compel lead agencies and local politicians to mandate that all patients who meet CDC field triage criteria be brought to level I centers? Moreover, on this basis, can we go to the CDC and demand that the field triage criteria be written more explicitly and related to time and distance?
Next issue, although the data are impressive regarding the relationship between admission volume and survival, and are totally concordant with the work that Avery Nathens did a number of years ago, let's consider what would happen if we applied your data to our trauma system as it stands today. 5 According to the ACS COT Resources for Optimal Care of the Injured Patient, 1200 total admissions are required to meet level I trauma center standards. So, based on actual numbers, if you increase the requirement to 1500, by your data you improve the odds ratio for survival by 0.11, and you wipe out 25 level I trauma centers. If you increase the requirement to 2000, the odds ratio goes up by 0.25, but a total of 121 level I trauma centers no longer meet the standard. If you increase to 3000, you improve the odds ratio by 0.39 but now, you have eliminated 144 trauma centers, and you only have 23 verified level I trauma centers remaining in the country. Get the picture?
So, my second question is "Is the evidence strong enough to change the volume criteria for level I centers and bear the unintended consequences of eliminating or downgrading a number of them? At the same time, shouldn't we establish volume criteria for level II centers as well?
You see, it's just not that simple. In a free-market society, with a federation of states where local governments rule and capitalism prevails, it's going to take a lot more than an excellent study like this-and it is excellent-to get the job done for injured Americans. It's going to take adherence to high-minded values, integrity, and political courage for local governments, all of which seems to be in short supply these days.
Response From J. Minei:
Dr Rotondo, thank you for that excellent perspective, particularly in your recent role as the COT chair. I am sure you have lived this very question daily for 4 years.
Let me try to answer the second question first, about should we increase the volume criteria, thus decreasing the number of trauma centers. Of course, these questions don't have definitive answers, but I would say the answer is both "yes" and "no." Yes, perhaps in large cities where there are multiple level I trauma centers that are perhaps admitting 1200 or 1500 patients, where, if you made one of them a lead center, you could potentially have 1 center with 2000 to 3000plus admissions and potentially gain the benefit of this. In more rural areas, if that's the only trauma center out there, it probably doesn't really matter what level they are per se, all the patients are going to go to those centers anyhow.
A lot easier said than done. I recognize the politics involved in my city and many of the cities of the people sitting in here. There are multiple level I trauma centers all vying for the same number of patients. So it's a great question without answer other than to say that the majority of the data support that high-volume centers deliver better care.
With respect to your first question regarding whether we should go back to the CDC relates to the second question. Again, those are bigger decisions that need to be made. The CDC, as you say, in the field triage guidelines has hedged, parenthetically, and states patients should be brought to the highest-level trauma center. In our own city, we are trying to do that and are getting the pushback that you suggest, although not from level II trauma centers but from the EMS groups who are saying, we don't want to drive that far to a level I center.
So both politically charged questions that I don't have a direct answer for, but thank you for your comments.
